Activity of cefepime/zidebactam (WCK 5222) against ‘problem’ antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory
Shazad Mushtaq(Public Health England), David M. Livermore(University of East Anglia)
Cited by 40
Related Papers
Outbreak of Infections Caused by <i>Pseudomonas aeruginosa</i> Producing VIM-1 Carbapenemase in Greece
|Journal of Clinical Microbiology|2000|261
OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’
|Journal of Antimicrobial Chemotherapy|2015|167
The threat from the pink corner
|Annals of Medicine|2003|93
Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015–16
|Journal of Antimicrobial Chemotherapy|2017|76
Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases
|Journal of Antimicrobial Chemotherapy|2015|65